Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
03/1999
03/16/1999US5882864 Biomarkers and targets for diagnosis, prognosis and management of prostate disease
03/16/1999US5882860 Hybridization of nucleic acid derived from cell with polynucleotide; genetic engineering; suppressing gene expression
03/16/1999US5882643 Identification and characterization of such factors which can play a role in preventing, ameliorating or correcting infections, dysfunctions or diseases. a novel lep gene of streptococcus pneumoniae.
03/16/1999CA2244232A1 Novel def
03/16/1999CA2236363A1 Novel compound
03/11/1999WO1999011796A1 Hnk-1 sulfotransferase and methods of use therefor
03/11/1999WO1999011789A1 Genetic engineering of cells to enhance healing and tissue regeneration
03/11/1999WO1999011788A1 Kringle1
03/11/1999WO1999011787A1 DNA PARTICIPATING IN REGULATION OF EXPRESSION O PEBP2 αA GENE, AND USE THEREOF
03/11/1999WO1999011786A1 pancpin GENE AND COMPOSITION FOR GENE THERAPY
03/11/1999WO1999011782A1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof
03/11/1999WO1999011781A1 Recombinant human erythropoietin with advantageous glycosylation profile
03/11/1999WO1999011780A2 Conductine protein and a related agent for diagnosing and treating tumor illnesses
03/11/1999WO1999011761A1 Suspension culture of retroviral producer cells
03/11/1999WO1999011759A1 GLUCOSE RESPONSIVE β-CELL LINE
03/11/1999WO1999011758A2 Cultures of human cns neural stem cells
03/11/1999WO1999011753A1 SpoOJ2 OF STAPHYLOCOCCUS AUREUS
03/11/1999WO1999011664A1 Genetically engineered cells which express bone morphogenetic proteins
03/11/1999WO1999011652A1 Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression
03/11/1999WO1999011293A1 50 human secreted proteins
03/11/1999WO1999011292A2 Compositions and methods for treating arthritis utilizing gene therapy
03/11/1999WO1999011291A1 A method of inducing apoptosis in human brain tumor cells using nerve growth factor
03/11/1999WO1999011288A1 Sr-bi antagonists and use thereof as contraceptives and in the treatment of steroidal overproduction
03/11/1999WO1999011283A1 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase
03/11/1999WO1998055512A3 Smad-interacting polypeptides and their use
03/11/1999WO1998055507A3 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and kinase domain
03/11/1999WO1998054212A3 Human type 3 ryanodine receptor protein and dna molecules coding therefor
03/11/1999WO1998049300A3 Truncated vegf-related proteins
03/11/1999WO1998047914A3 Us6 gene from the human cytomegalovirus (hcmv)
03/11/1999WO1998046258A3 Use of chondroitinase in the manufacture of a medicament in the treatment and prevention of mucoid secretions
03/11/1999WO1998044788A3 Animal model for evaluation of vaccines
03/11/1999CA2682108A1 Methods for generating high titer helper-free preparations of recombinant aav vectors
03/11/1999CA2303476A1 Recombinant human erythropoietin with advantageous glycosylation profile
03/11/1999CA2303418A1 Dna participating in regulation of expression o pebp2 .alpha.a gene, and use thereof
03/11/1999CA2302830A1 Glucose responsive .beta.-cell line
03/11/1999CA2302484A1 Cultures of human cns neural stem cells
03/11/1999CA2302403A1 Sr-bi antagonists and use thereof as contraceptives and in the treatment of steroidal overproduction
03/11/1999CA2302168A1 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase
03/11/1999CA2301882A1 Genetically engineered cells which express bone morphogenetic proteins
03/10/1999EP0900849A1 Receptor-mediated gene transfer system for targeting tumor gene therapy
03/10/1999EP0900848A2 MecB polynucleotides and polypeptides from the Clpc ATPase family of Stapyloccoccus aureus
03/10/1999EP0900847A2 Phosphoribosyl transferase from Staphylococcus aureus
03/10/1999EP0900846A2 Nucleic acid encoding Streptococcus pneumoniae response regulator
03/10/1999EP0900845A2 Signal recognition particle polypeptides and polynucleotides
03/10/1999EP0900844A2 Membrane protein of Staphylococcus aureus
03/10/1999EP0900843A2 FfH polypeptide from Streptococcus
03/10/1999EP0900280A2 Use of a polypeptide as cell receptor for adenoviruses
03/10/1999EP0900275A1 Methods and reagents for modulating apoptosis
03/10/1999EP0900273A2 A family of organic anion transporters, nucleic acids encoding them, cells comprising them and methods for using them
03/10/1999CN1210541A Process for preparing purified nucleic acid and use thereof
03/10/1999CA2243670A1 Novel histidine kinase
03/09/1999US5880276 Nucleotide sequence comprising a constitutive transport enhancer which functions to transport mrna transcripts from the nucleus to the cytoplasm of a cell.
03/09/1999US5880263 Human chemotactic protein
03/09/1999US5880261 Diagnosis, and prophylactic and therapeutic treatment of conditions such as diabetes and neurological diseases such as dementia and/or parkinsonism.
03/09/1999US5880152 Inflammatory bowel disease
03/09/1999US5880105 Human galactokinase gene
03/09/1999US5880104 Administering a plasmid vector encoding a fusion protein lacking a transmembrane region
03/09/1999US5880102 Adenoviral vector system
03/09/1999US5879908 CRFG-1a, a target and marker for chronic renal failure
03/09/1999US5879893 Hybridization method for detecting polynucleotides coding for signal transduction inhibitor protein in body fluids and tissue samples; treatment of alzheimer's disease and cancer
03/09/1999US5879892 Relates to nucleic acid molecules and encoded polypeptides which are expressed preferentially in leukemia.
03/09/1999US5879687 Enhancing or eliciting cellular and/or humoral immune response, for treating tumors
03/09/1999CA2243656A1 Response regulator
03/09/1999CA1340427C Genetic modification of endothelial cells
03/04/1999WO1999010516A2 Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta
03/04/1999WO1999010510A2 Fusion proteins comprising a dimerization, trimerization or tetramerization domain and an additional heterologous transcription activation, transcription repression, dna binding or ligand binding domain
03/04/1999WO1999010508A1 Chimeric transcriptional activators and compositions and uses related thereto
03/04/1999WO1999010505A2 Production of proteins in eggs
03/04/1999WO1999010501A1 Apoptosis-associated nuclease cpan
03/04/1999WO1999010496A1 Tuberculosis vaccine
03/04/1999WO1999010486A2 Mdm2-specific antisense oligonucleotides
03/04/1999WO1999010480A2 New tissue-specific calpaines, their production and their use
03/04/1999WO1999010364A1 Follistatin-3
03/04/1999WO1999010363A1 29 human secreted proteins
03/04/1999WO1999010337A1 Tetraether lipid derivatives and liposomes and lipid agglomerates containing tetraetherlipid derivatives, and use thereof
03/04/1999WO1999010014A2 Receptor-mediated gene delivery using bacteriophage vectors
03/04/1999WO1999010013A1 The use of insulin-like growth factor-i in muscle
03/04/1999WO1999010012A1 NOVEL priA
03/04/1999WO1999010003A1 Androgen activity antagonists as therapies for anorexia, anorexia nervosa, and disorders characterized by a pathologically underweight condition
03/04/1999WO1999010001A1 Carcinostatic agents
03/04/1999WO1999009817A1 Use of mariner transposan in the production of transgenic animals
03/04/1999WO1998055641A3 Somatic gene therapy to suppress secondary cataract formation
03/04/1999WO1998055639A3 Recombinant adenoviral vectors comprising a splicing sequence
03/04/1999WO1998055607A3 Tumor targeted vector
03/04/1999WO1998055606A3 Lactoferrin receptor genes of moraxella
03/04/1999WO1998054310A3 Methods for activating inactive genes and methods for altering the rate of development of cells, tissues and organisms
03/04/1999DE19737105A1 Neue gewebsspezifische Calpaine, ihre Herstellung und Verwendung New tissue-specific calpain, their preparation and use
03/04/1999CA2311116A1 Production of proteins in eggs
03/04/1999CA2303482A1 Chimeric transcriptional activators and compositions and uses related thereto
03/04/1999CA2302525A1 Follistatin-3
03/04/1999CA2302387A1 29 human secreted proteins
03/04/1999CA2302293A1 Receptor-mediated gene delivery using bacteriophage vectors
03/04/1999CA2301879A1 Tuberculosis vaccine
03/04/1999CA2301816A1 Mdm2-specific antisense oligonucleotides
03/04/1999CA2301815A1 New tissue-specific calpaines, their production and their use
03/04/1999CA2301780A1 Androgen activity antagonists as therapies for anorexia, anorexia nervosa, and disorders characterized by a pathologically underweight condition
03/04/1999CA2300972A1 Use of mariner transposan in the production of transgenic animals
03/04/1999CA2300376A1 Fusion proteins comprising a dimerization, trimerization or tetramerization domain and an additional heterologous transcription activation, transcription repression, dna binding or ligand binding domain
03/04/1999CA2242260A1 Spo0j1
03/04/1999CA2242258A1 Novel compounds
1 ... 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 ... 870